BioWorld MedTech

Jan. 4, 2010

Technique uses patient's veins to replace infected aortic grafts

A new technique designed to replace infected aortic grafts with the person's own veins is proving to be more durable and less prone to new infection than those procedures which use synthetic and cadaver grafts. (Medical Device Daily) Read More

Deals roundup: Anika buys FAB for $17.1M and nearly 2 million shares

Washington roundup: NICE recommends limited use of ablation for CRC to liver

John's Hopkins to study value of text messaging with patients

Report from Europe: Wright Medical to spend $4M to move French operations

Holiday notice

Today's MDD food for med-tech thought

Med-Tech Notes

Agreements/contracts: Acacia subsidiary licenses PACS technology to Stryker

Product Briefs

People in the News

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 12, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld Science

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...